Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,429 | 35,070 | 43,215 | 47,428 | 73,048 |
| Marketable Securities | 204,431 | 189,238 | 178,075 | 143,948 | 118,083 |
| Receivables | 155,162 | 144,377 | 146,229 | 115,116 | 106,688 |
| Inventories | 38,879 | 37,391 | 22,634 | 22,419 | 16,324 |
| TOTAL | $467,671 | $438,056 | $411,232 | $349,224 | $332,778 |
| Non-Current Assets | |||||
| PPE Net | 872 | 1,040 | 1,043 | 1,215 | 1,394 |
| Intangibles | 13,687 | 14,250 | 14,812 | 15,375 | 15,937 |
| Other Non-Current Assets | 6,307 | 6,657 | 5,886 | 5,163 | 2,324 |
| TOTAL | $20,866 | $21,947 | $21,741 | $21,753 | $19,655 |
| Total Assets | $488,537 | $460,003 | $432,973 | $370,977 | $352,433 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,950 | 7,950 | 1,000 | 1,000 | 1,000 |
| Accounts payable and accrued liabilities | 6,604 | 18,296 | 12,528 | 5,795 | 15,082 |
| Accrued Expenses | 146,786 | 136,957 | 116,310 | 92,975 | 87,854 |
| TOTAL | $160,340 | $163,203 | $129,838 | $99,770 | $103,936 |
| Non-Current Liabilities | |||||
| Long Term Debt | 101,950 | 101,470 | 107,959 | 107,498 | 107,049 |
| Other Non-Current Liabilities | 5,668 | 5,682 | 5,697 | 5,636 | 2,474 |
| TOTAL | $107,618 | $107,152 | $113,656 | $113,134 | $109,523 |
| Total Liabilities | $267,958 | $270,355 | $243,494 | $212,904 | $213,459 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,692 | 125,083 | 124,033 | 122,492 | 119,905 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,134,370 | -1,149,379 | -1,138,084 | -1,155,479 | -1,162,889 |
| Other shareholders' equity | -656 | -514 | -44 | -62 | -35 |
| TOTAL | $220,579 | $189,648 | $189,479 | $158,073 | $138,974 |
| Total Liabilities And Equity | $488,537 | $460,003 | $432,973 | $370,977 | $352,433 |